newsfilter
← Latest News
GlobeNewswire·

Galecto Reports Third Quarter 2025 Operating and Financial Results

BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today announced its